The post KAS Comprehensive Technical Review: January 19, 2026 Full Analysis appeared on BitcoinEthereumNews.com. KAS is trading within a strong downtrend; SupertrendThe post KAS Comprehensive Technical Review: January 19, 2026 Full Analysis appeared on BitcoinEthereumNews.com. KAS is trading within a strong downtrend; Supertrend

KAS Comprehensive Technical Review: January 19, 2026 Full Analysis

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

KAS is trading within a strong downtrend; Supertrend resistance at $0.05 level is dominant. RSI at 38.62 is approaching oversold but MACD with negative histogram confirms bearish momentum. Critical supports at $0.0425 and $0.0403 will be tested, BTC correlation risky for altcoins. Short-term short bias prominent, risk/reward ratio weak for longs.

Executive Summary

KAS/USDT pair is trading at $0.04 as of January 19, 2026, showing a -3.02% decline in the last 24 hours. Market structure indicates a clear downtrend: Price remains below EMA20 ($0.05), Supertrend gives bearish signal, and resistance at $0.05 is strong. Momentum indicators (RSI 38.62, MACD negative) confirm selling pressure, while volume at $15.85M signals limited participation. Multi-timeframe analysis identifies 12 critical levels (1D: 2S/3R, 3D: 2S/3R, 1W: 3S/4R). Bullish target $0.0597 (low score 25), bearish target $0.0236 (score 22). Despite BTC’s uptrend, Supertrend being bearish mandates caution for altcoins. Strategic outlook: Short-term selling opportunities, aggressive shorts on support breaks; for longs, stop-loss below $0.0403 is essential.

Market Structure and Trend Status

Current Trend Analysis

KAS is positioned within medium- and short-term downtrend. On the daily chart, higher high/lower low structure is broken, price has retraced over 20% from recent highs. Supertrend indicator is in bearish mode and positions $0.05 as resistance – this level has been rejected twice in the last 3 days. Short-term trend remains bearish as long as price stays below EMA20 ($0.05); a volume-backed buying wave is required to break above this EMA. On the weekly timeframe, approaching lower bands of the downtrend channel, signaling momentum loss. Overall trend confluence 80% bearish: Structural breaks to be tested at support levels.

Structural Levels

Main structural supports: $0.0425 (score 75/100, 1D/3D confluence), $0.0403 (score 69/100, 1W support). These levels align with Fibonacci retracement 38.2% and 50% levels. Resistances: $0.0432 (score 69/100, short-term pivot), $0.0476 (score 67/100, EMA20 confluence), $0.0511 (score 62/100, weekly resistance). Multi-timeframe totals 12 strong levels: Support weight concentrated at lower end, resistances dominant above. Breakout scenarios: Below $0.0403 → $0.0236 bearish target; above $0.0432 → test $0.0597.

Technical Indicators Report

Momentum Indicators

RSI(14) at 38.62; approaching oversold threshold (30) with short-term divergence risk but bearish momentum intact – no negative divergence in last 5 candles. MACD histogram negative and line/signal crossover downward, confirming bearish momentum 100%. Stochastic at 25%, selling pressure continues. Momentum confluence bearish: High probability of RSI declining to 30 short-term, potentially triggering $0.0403 support.

Trend Indicators

EMA stack bearish: Price below EMA20 ($0.05), EMA50 ($0.055), and EMA200 ($0.06). EMA20 acting as resistance, death cross (EMA20/50) active. Supertrend ATR-based bearish signal, trail stop at $0.05. Price below Ichimoku cloud, Tenkan/Kijun death cross complete. Trend indicators 90% bearish signal: EMA20 breakout + volume increase mandatory for uptrend reversal.

Critical Support and Resistance Analysis

Supports detailed: $0.0425 (75/100) – 1D low + Fib 38.2%, high test probability; $0.0403 (69/100) – 3D/1W confluence, cascade risk on break. Resistances: $0.0432 (69/100) – pivot high, first short-covering level; $0.0476 (67/100) – EMA20/Supertrend; $0.0511 (62/100) – weekly R1. Volume profile shows $0.0425 high-volume node, $0.05 low-volume gap. Scenario: 70% probability test $0.0425, 20% bounce, 10% direct break. Watch: $0.0432 false breakout trap.

Volume and Market Participation

24h volume $15.85M – at 60% of average volume, showing low participation despite bearish price action (OBV negative divergence). Volume spikes in recent drops confirm support breaks, but buying volume weak. Price below VWAP $0.0412, institutional selling signal. Participation low: Retail selling dominant, no whale accumulation. Volume increase critical for bounce at $0.0425; otherwise slide to $0.0403 likely. Overall: 75% bearish volume confluence.

Risk Assessment

Risk/reward calculation: From current $0.04, bullish target $0.0597 (+49.25%, score 25/100), bearish $0.0236 (-41%, score 22/100). Long R/R: 1:0.8 (weak), short R/R: 1:1.2 (positive). Key risks: BTC dump (below $92,915) drags KAS to $0.03s; BTC bounce (above $94,151) creates short squeeze. Volatility high (ATR 8%), stop-loss: Longs $0.0395, shorts $0.0440. Position size: 1-2% risk/capital. Macro risk: BTC dominance rise crushes altcoins. Balanced view: Short bias, 60% down probability.

Bitcoin Correlation

BTC $93,068 (-2.22%), in uptrend but Supertrend bearish – caution for altcoins. KAS/BTC pair at 0.00043 in downtrend, correlation 0.85. If BTC key supports $92,915/$90,921 break, KAS $0.0403 breaks; on resistances $94,151/$96,160 test, KAS rebounds to $0.0432. BTC dominance Supertrend bearish: Altseason distant, KAS amplifies BTC moves 1.5x. Watch: BTC below $92,915 → aggressive KAS short; above $94,151 → partial long.

Conclusion and Strategic Outlook

KAS technical picture bearish: Downtrend structure, indicator confluence (85% bearish), low volume, and BTC risks support short-term selling. Critical tests at $0.0425/$0.0403 supports; break leads to $0.0236. For longs, EMA20 ($0.05) close required, but low-score target risky. Strategy: Short entry below $0.0425 in KAS Spot Analysis, target $0.0403; 3-5x leverage short in KAS Futures Analysis. Risk management priority: Market volatile, no news flow but BTC-focused trade. Long-term: Accumulation zone below $0.0236. Full picture: Wait and hunt short opportunities.

This analysis uses the market views and methodology of Chief Analyst Devrim Cacal.

Trading Analyst: Emily Watson

Short-term trading strategies expert

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/kas-comprehensive-technical-review-january-19-2026-full-analysis

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
US, UK, Canada Launch Operation Atlantic to Tackle Crypto Scams

US, UK, Canada Launch Operation Atlantic to Tackle Crypto Scams

Law enforcement agencies from the United States, United Kingdom, and Canada have launched Operation Atlantic, a joint effort to combat rising crypto scams and protect
Share
Coinlaw2026/03/17 22:11